Medical software developer Ayogo had a healthy check-up with investors in April.
The Vancouver-based startup has announced it raised $2.5 million in series A funding to help expand its product line globally.
Ayogo develops games for patients with chronic conditions and in the past it has partnered with the Diabetes Hands Foundation to create games where players take on missions and are rewarded for real-life eating decisions that improve their health.
Investors from the latest funding round include Merck Global Health Innovation Fund, Excel Venture Management and 7Wire Ventures. Merck’s David Stevenson, Excel’s Caleb Winder and 7 Wire’s Lee Shapiro will join the company’s board of directors.
In an April 9 statement, Ayogo CEO Michael Fergusson credited much of the funding success with the company’s participation in the Canadian Technology Accelerator (CTA) program in Boston in 2013 and 2014.
The CTA provides early stage companies with office space and networking opportunities for Canadian entrepreneurs looking for funding in the Silicon Valley, New York, Denver, Philadelphia and Boston.
Nearly 130 companies were accepted into the CTA program last year, including 21 from B.C. While B.C. accounts for 12.5% of Canada’s population, its representation in the program accounts for 21% of participating companies.
